BRIEF-Alnylam Pharmaceuticals reports Q1 GAAP loss per share $1.21 including items
May 02, 2016 at 16:08 PM EDT
* Q1 earnings per share view $-1.05 -- Thomson Reuters I/B/E/S
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.